<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.2478  Trenbolone acetate and estradiol benzoate.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications--(1) Each implant consists of:</p><p class="depth2"><em>(1)</em> Each implant consists of:</p><p class="depth3"><em>(i)</em> 8 pellets, each pellet containing 25 milligrams (mg) trenbolone acetate and 3.5 mg estradiol benzoate.</p><p class="depth3"><em>(ii)</em> 4 pellets, each pellet containing 25 mg trenbolone acetate and 3.5 mg estradiol benzoate.</p><p class="depth2"><em>(2)</em> Each extended release implant consists of:</p><p class="depth3"><em>(i)</em> 8 pellets with a porous polymer film coating, each pellet containing 25 mg trenbolone acetate and 3.5 mg estradiol benzoate.</p><p class="depth3"><em>(ii)</em> 6 pellets with a porous polymer film coating, each pellet containing 25 mg trenbolone acetate and 3.5 mg estradiol benzoate.</p><p class="depth1"><em>(b)</em> Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Related tolerances. See Sec. Sec. 556.240 and 556.739 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions of use--(1) Steers fed in confinement for slaughter. (i) For an implant as described in paragraph (a)(1)(i) of this section:</p><p class="depth2"><em>(1)</em> Steers fed in confinement for slaughter. (i) For an implant as described in paragraph (a)(1)(i) of this section:</p><p class="depth3"><em>(i)</em> For an implant as described in paragraph (a)(1)(i) of this section:</p><p class="depth4"><em>(A)</em> Amount. 200 mg trenbolone acetate and 28 mg estradiol benzoate.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain and improved feed efficiency.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth3"><em>(ii)</em> For an implant as described in paragraph (a)(1)(ii) of this section:</p><p class="depth4"><em>(A)</em> Amount. 100 mg trenbolone acetate and 14 mg estradiol benzoate.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth3"><em>(iii)</em> For an implant as described in paragraph (a)(2)(i) of this section:</p><p class="depth4"><em>(A)</em> Amount. 200 mg trenbolone acetate and 28 mg estradiol benzoate in an extended release implant.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain and improved feed efficiency for up to 200 days.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth2"><em>(2)</em> Heifers fed in confinement for slaughter--(i) For an implant as described in paragraph (a)(1)(i) of this section:</p><p class="depth3"><em>(i)</em> For an implant as described in paragraph (a)(1)(i) of this section:</p><p class="depth4"><em>(A)</em> Amount. 200 mg trenbolone acetate and 28 mg estradiol benzoate.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Not for use in dairy or beef replacement heifers. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth3"><em>(ii)</em> For an implant as described in paragraph (a)(1)(ii) of this section:</p><p class="depth4"><em>(A)</em> Amount. 100 mg trenbolone acetate and 14 mg estradiol benzoate.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain and improved feed efficiency.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Not for use in dairy or beef replacement heifers. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth3"><em>(iii)</em> For an implant as described in paragraph (a)(2)(i) of this section:</p><p class="depth4"><em>(A)</em> Amount. 200 mg trenbolone acetate and 28 mg estradiol benzoate in an extended release implant.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain and improved feed efficiency for up to 200 days.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Not for use in dairy or beef replacement heifers. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth2"><em>(3)</em> Pasture steers and heifers (slaughter, stocker, and feeder)--(i) For an implant as described in paragraph (a)(2)(ii) of this section:</p><p class="depth3"><em>(i)</em> For an implant as described in paragraph (a)(2)(ii) of this section:</p><p class="depth4"><em>(A)</em> Amount. 150 mg trenbolone acetate and 21 mg estradiol benzoate in an extended release implant.</p><p class="depth4"><em>(B)</em> Indications for use. For increased rate of weight gain for up to 200 days.</p><p class="depth4"><em>(C)</em> Limitations. Implant subcutaneously in ear only. Not for use in dairy or beef replacement heifers. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.</p><p class="depth3"><em>(ii)</em> [Reserved]
[67 FR 78972, Dec. 27, 2002, as amended at 69 FR 67818, Nov. 22, 2004; 79 FR 16197, Mar. 25, 2014; 79 FR 64116, Oct. 28, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
